The 2 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 16.50, with a high estimate of 27.00 and a low estimate of 6.00. The median estimate represents a +816.67% increase from the last price of 1.80.
The current consensus among 1 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.08
Reporting Date Feb 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.